The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sevoflurane Anesthesia Market Research Report 2024
Synopsis
Sevoflurane is a fluorine-containing inhaled anesthetic.The minimum alveolar concentration (MAC) was 0.66% in the mixture of oxygen and nitrous oxide.1.7% in pure oxygen;Similar to the enflurane, 1/2 as much as the flurane.The lethal concentration (LC50)/MAC was higher than that of enflurane.The induction time was shorter than that of enflurane and flurane.
The global Sevoflurane Anesthesia market was valued at US$ 1219.2 million in 2023 and is anticipated to reach US$ 1608.9 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
North American market for Sevoflurane Anesthesia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sevoflurane Anesthesia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sevoflurane Anesthesia include Abbott, Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui, Hebei Yipin Pharmaceutical and Lunan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sevoflurane Anesthesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane Anesthesia.
Report Scope
The Sevoflurane Anesthesia market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevoflurane Anesthesia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane Anesthesia manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Hebei Yipin Pharmaceutical
Lunan
Segment by Type
by Capacity
120ml
250ml
by Management category
Original Drugs
Generic Drugs
Segment by Application
For Human Use
For Animal Use
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevoflurane Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevoflurane Anesthesia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sevoflurane is a fluorine-containing inhaled anesthetic.The minimum alveolar concentration (MAC) was 0.66% in the mixture of oxygen and nitrous oxide.1.7% in pure oxygen;Similar to the enflurane, 1/2 as much as the flurane.The lethal concentration (LC50)/MAC was higher than that of enflurane.The induction time was shorter than that of enflurane and flurane.
The global Sevoflurane Anesthesia market was valued at US$ 1219.2 million in 2023 and is anticipated to reach US$ 1608.9 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
North American market for Sevoflurane Anesthesia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sevoflurane Anesthesia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sevoflurane Anesthesia include Abbott, Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui, Hebei Yipin Pharmaceutical and Lunan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sevoflurane Anesthesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane Anesthesia.
Report Scope
The Sevoflurane Anesthesia market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevoflurane Anesthesia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane Anesthesia manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Hebei Yipin Pharmaceutical
Lunan
Segment by Type
by Capacity
120ml
250ml
by Management category
Original Drugs
Generic Drugs
Segment by Application
For Human Use
For Animal Use
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevoflurane Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevoflurane Anesthesia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sevoflurane Anesthesia Market Overview
1.1 Product Overview and Scope of Sevoflurane Anesthesia
1.2 Sevoflurane Anesthesia Segment by Capacity
1.2.1 Global Sevoflurane Anesthesia Market Value Comparison by Capacity (2024-2030)
1.2.2 120ml
1.2.3 250ml
1.3 Sevoflurane Anesthesia Segment by Application
1.3.1 Global Sevoflurane Anesthesia Market Value by Application: (2024-2030)
1.3.2 For Human Use
1.3.3 For Animal Use
1.4 Global Sevoflurane Anesthesia Market Size Estimates and Forecasts
1.4.1 Global Sevoflurane Anesthesia Revenue 2019-2030
1.4.2 Global Sevoflurane Anesthesia Sales 2019-2030
1.4.3 Global Sevoflurane Anesthesia Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sevoflurane Anesthesia Market Competition by Manufacturers
2.1 Global Sevoflurane Anesthesia Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sevoflurane Anesthesia Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sevoflurane Anesthesia Average Price by Manufacturers (2019-2024)
2.4 Global Sevoflurane Anesthesia Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sevoflurane Anesthesia, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sevoflurane Anesthesia, Product Type & Application
2.7 Sevoflurane Anesthesia Market Competitive Situation and Trends
2.7.1 Sevoflurane Anesthesia Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sevoflurane Anesthesia Players Market Share by Revenue
2.7.3 Global Sevoflurane Anesthesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sevoflurane Anesthesia Retrospective Market Scenario by Region
3.1 Global Sevoflurane Anesthesia Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sevoflurane Anesthesia Global Sevoflurane Anesthesia Sales by Region: 2019-2030
3.2.1 Global Sevoflurane Anesthesia Sales by Region: 2019-2024
3.2.2 Global Sevoflurane Anesthesia Sales by Region: 2025-2030
3.3 Global Sevoflurane Anesthesia Global Sevoflurane Anesthesia Revenue by Region: 2019-2030
3.3.1 Global Sevoflurane Anesthesia Revenue by Region: 2019-2024
3.3.2 Global Sevoflurane Anesthesia Revenue by Region: 2025-2030
3.4 North America Sevoflurane Anesthesia Market Facts & Figures by Country
3.4.1 North America Sevoflurane Anesthesia Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sevoflurane Anesthesia Sales by Country (2019-2030)
3.4.3 North America Sevoflurane Anesthesia Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sevoflurane Anesthesia Market Facts & Figures by Country
3.5.1 Europe Sevoflurane Anesthesia Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sevoflurane Anesthesia Sales by Country (2019-2030)
3.5.3 Europe Sevoflurane Anesthesia Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sevoflurane Anesthesia Market Facts & Figures by Country
3.6.1 Asia Pacific Sevoflurane Anesthesia Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sevoflurane Anesthesia Sales by Country (2019-2030)
3.6.3 Asia Pacific Sevoflurane Anesthesia Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sevoflurane Anesthesia Market Facts & Figures by Country
3.7.1 Latin America Sevoflurane Anesthesia Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sevoflurane Anesthesia Sales by Country (2019-2030)
3.7.3 Latin America Sevoflurane Anesthesia Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sevoflurane Anesthesia Market Facts & Figures by Country
3.8.1 Middle East and Africa Sevoflurane Anesthesia Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sevoflurane Anesthesia Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sevoflurane Anesthesia Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sevoflurane Anesthesia Sales by Type (2019-2030)
4.1.1 Global Sevoflurane Anesthesia Sales by Type (2019-2024)
4.1.2 Global Sevoflurane Anesthesia Sales by Type (2025-2030)
4.1.3 Global Sevoflurane Anesthesia Sales Market Share by Type (2019-2030)
4.2 Global Sevoflurane Anesthesia Revenue by Type (2019-2030)
4.2.1 Global Sevoflurane Anesthesia Revenue by Type (2019-2024)
4.2.2 Global Sevoflurane Anesthesia Revenue by Type (2025-2030)
4.2.3 Global Sevoflurane Anesthesia Revenue Market Share by Type (2019-2030)
4.3 Global Sevoflurane Anesthesia Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sevoflurane Anesthesia Sales by Application (2019-2030)
5.1.1 Global Sevoflurane Anesthesia Sales by Application (2019-2024)
5.1.2 Global Sevoflurane Anesthesia Sales by Application (2025-2030)
5.1.3 Global Sevoflurane Anesthesia Sales Market Share by Application (2019-2030)
5.2 Global Sevoflurane Anesthesia Revenue by Application (2019-2030)
5.2.1 Global Sevoflurane Anesthesia Revenue by Application (2019-2024)
5.2.2 Global Sevoflurane Anesthesia Revenue by Application (2025-2030)
5.2.3 Global Sevoflurane Anesthesia Revenue Market Share by Application (2019-2030)
5.3 Global Sevoflurane Anesthesia Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Sevoflurane Anesthesia Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Sevoflurane Anesthesia Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi Pharmaceutical
6.3.1 Maruishi Pharmaceutical Corporation Information
6.3.2 Maruishi Pharmaceutical Description and Business Overview
6.3.3 Maruishi Pharmaceutical Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Maruishi Pharmaceutical Sevoflurane Anesthesia Product Portfolio
6.3.5 Maruishi Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporation Information
6.4.2 Jiangsu Hengrui Description and Business Overview
6.4.3 Jiangsu Hengrui Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Hengrui Sevoflurane Anesthesia Product Portfolio
6.4.5 Jiangsu Hengrui Recent Developments/Updates
6.5 Hebei Yipin Pharmaceutical
6.5.1 Hebei Yipin Pharmaceutical Corporation Information
6.5.2 Hebei Yipin Pharmaceutical Description and Business Overview
6.5.3 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Product Portfolio
6.5.5 Hebei Yipin Pharmaceutical Recent Developments/Updates
6.6 Lunan
6.6.1 Lunan Corporation Information
6.6.2 Lunan Description and Business Overview
6.6.3 Lunan Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lunan Sevoflurane Anesthesia Product Portfolio
6.6.5 Lunan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sevoflurane Anesthesia Industry Chain Analysis
7.2 Sevoflurane Anesthesia Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sevoflurane Anesthesia Production Mode & Process
7.4 Sevoflurane Anesthesia Sales and Marketing
7.4.1 Sevoflurane Anesthesia Sales Channels
7.4.2 Sevoflurane Anesthesia Distributors
7.5 Sevoflurane Anesthesia Customers
8 Sevoflurane Anesthesia Market Dynamics
8.1 Sevoflurane Anesthesia Industry Trends
8.2 Sevoflurane Anesthesia Market Drivers
8.3 Sevoflurane Anesthesia Market Challenges
8.4 Sevoflurane Anesthesia Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sevoflurane Anesthesia Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sevoflurane Anesthesia Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sevoflurane Anesthesia Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sevoflurane Anesthesia Sales (Litre) of Key Manufacturers (2019-2024)
Table 5. Global Sevoflurane Anesthesia Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sevoflurane Anesthesia Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sevoflurane Anesthesia Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sevoflurane Anesthesia Average Price (US$/Litre) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sevoflurane Anesthesia, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sevoflurane Anesthesia, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sevoflurane Anesthesia, Product Type & Application
Table 12. Global Key Manufacturers of Sevoflurane Anesthesia, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sevoflurane Anesthesia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane Anesthesia as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sevoflurane Anesthesia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sevoflurane Anesthesia Sales by Region (2019-2024) & (Litre)
Table 18. Global Sevoflurane Anesthesia Sales Market Share by Region (2019-2024)
Table 19. Global Sevoflurane Anesthesia Sales by Region (2025-2030) & (Litre)
Table 20. Global Sevoflurane Anesthesia Sales Market Share by Region (2025-2030)
Table 21. Global Sevoflurane Anesthesia Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sevoflurane Anesthesia Revenue Market Share by Region (2019-2024)
Table 23. Global Sevoflurane Anesthesia Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sevoflurane Anesthesia Revenue Market Share by Region (2025-2030)
Table 25. North America Sevoflurane Anesthesia Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sevoflurane Anesthesia Sales by Country (2019-2024) & (Litre)
Table 27. North America Sevoflurane Anesthesia Sales by Country (2025-2030) & (Litre)
Table 28. North America Sevoflurane Anesthesia Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sevoflurane Anesthesia Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sevoflurane Anesthesia Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sevoflurane Anesthesia Sales by Country (2019-2024) & (Litre)
Table 32. Europe Sevoflurane Anesthesia Sales by Country (2025-2030) & (Litre)
Table 33. Europe Sevoflurane Anesthesia Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sevoflurane Anesthesia Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sevoflurane Anesthesia Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sevoflurane Anesthesia Sales by Region (2019-2024) & (Litre)
Table 37. Asia Pacific Sevoflurane Anesthesia Sales by Region (2025-2030) & (Litre)
Table 38. Asia Pacific Sevoflurane Anesthesia Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sevoflurane Anesthesia Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sevoflurane Anesthesia Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sevoflurane Anesthesia Sales by Country (2019-2024) & (Litre)
Table 42. Latin America Sevoflurane Anesthesia Sales by Country (2025-2030) & (Litre)
Table 43. Latin America Sevoflurane Anesthesia Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sevoflurane Anesthesia Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sevoflurane Anesthesia Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sevoflurane Anesthesia Sales by Country (2019-2024) & (Litre)
Table 47. Middle East & Africa Sevoflurane Anesthesia Sales by Country (2025-2030) & (Litre)
Table 48. Middle East & Africa Sevoflurane Anesthesia Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sevoflurane Anesthesia Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sevoflurane Anesthesia Sales (Litre) by Type (2019-2024)
Table 51. Global Sevoflurane Anesthesia Sales (Litre) by Type (2025-2030)
Table 52. Global Sevoflurane Anesthesia Sales Market Share by Type (2019-2024)
Table 53. Global Sevoflurane Anesthesia Sales Market Share by Type (2025-2030)
Table 54. Global Sevoflurane Anesthesia Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sevoflurane Anesthesia Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sevoflurane Anesthesia Revenue Market Share by Type (2019-2024)
Table 57. Global Sevoflurane Anesthesia Revenue Market Share by Type (2025-2030)
Table 58. Global Sevoflurane Anesthesia Price (US$/Litre) by Type (2019-2024)
Table 59. Global Sevoflurane Anesthesia Price (US$/Litre) by Type (2025-2030)
Table 60. Global Sevoflurane Anesthesia Sales (Litre) by Application (2019-2024)
Table 61. Global Sevoflurane Anesthesia Sales (Litre) by Application (2025-2030)
Table 62. Global Sevoflurane Anesthesia Sales Market Share by Application (2019-2024)
Table 63. Global Sevoflurane Anesthesia Sales Market Share by Application (2025-2030)
Table 64. Global Sevoflurane Anesthesia Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sevoflurane Anesthesia Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sevoflurane Anesthesia Revenue Market Share by Application (2019-2024)
Table 67. Global Sevoflurane Anesthesia Revenue Market Share by Application (2025-2030)
Table 68. Global Sevoflurane Anesthesia Price (US$/Litre) by Application (2019-2024)
Table 69. Global Sevoflurane Anesthesia Price (US$/Litre) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 73. Abbott Sevoflurane Anesthesia Product
Table 74. Abbott Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 78. Baxter Sevoflurane Anesthesia Product
Table 79. Baxter Recent Developments/Updates
Table 80. Maruishi Pharmaceutical Corporation Information
Table 81. Maruishi Pharmaceutical Description and Business Overview
Table 82. Maruishi Pharmaceutical Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 83. Maruishi Pharmaceutical Sevoflurane Anesthesia Product
Table 84. Maruishi Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Hengrui Corporation Information
Table 86. Jiangsu Hengrui Description and Business Overview
Table 87. Jiangsu Hengrui Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 88. Jiangsu Hengrui Sevoflurane Anesthesia Product
Table 89. Jiangsu Hengrui Recent Developments/Updates
Table 90. Hebei Yipin Pharmaceutical Corporation Information
Table 91. Hebei Yipin Pharmaceutical Description and Business Overview
Table 92. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 93. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Product
Table 94. Hebei Yipin Pharmaceutical Recent Developments/Updates
Table 95. Lunan Corporation Information
Table 96. Lunan Description and Business Overview
Table 97. Lunan Sevoflurane Anesthesia Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 98. Lunan Sevoflurane Anesthesia Product
Table 99. Lunan Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Sevoflurane Anesthesia Distributors List
Table 103. Sevoflurane Anesthesia Customers List
Table 104. Sevoflurane Anesthesia Market Trends
Table 105. Sevoflurane Anesthesia Market Drivers
Table 106. Sevoflurane Anesthesia Market Challenges
Table 107. Sevoflurane Anesthesia Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sevoflurane Anesthesia
Figure 2. Global Sevoflurane Anesthesia Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sevoflurane Anesthesia Market Share by Type in 2023 & 2030
Figure 4. 120ml Product Picture
Figure 5. 250ml Product Picture
Figure 6. Global Sevoflurane Anesthesia Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sevoflurane Anesthesia Market Share by Application in 2023 & 2030
Figure 8. For Human Use
Figure 9. For Animal Use
Figure 10. Global Sevoflurane Anesthesia Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Sevoflurane Anesthesia Market Size (2019-2030) & (US$ Million)
Figure 12. Global Sevoflurane Anesthesia Sales (2019-2030) & (Litre)
Figure 13. Global Sevoflurane Anesthesia Average Price (US$/Litre) & (2019-2030)
Figure 14. Sevoflurane Anesthesia Report Years Considered
Figure 15. Sevoflurane Anesthesia Sales Share by Manufacturers in 2023
Figure 16. Global Sevoflurane Anesthesia Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Sevoflurane Anesthesia Players: Market Share by Revenue in 2023
Figure 18. Sevoflurane Anesthesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Sevoflurane Anesthesia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Sevoflurane Anesthesia Sales Market Share by Country (2019-2030)
Figure 21. North America Sevoflurane Anesthesia Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Sevoflurane Anesthesia Sales Market Share by Country (2019-2030)
Figure 25. Europe Sevoflurane Anesthesia Revenue Market Share by Country (2019-2030)
Figure 26. Germany Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Sevoflurane Anesthesia Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Sevoflurane Anesthesia Revenue Market Share by Region (2019-2030)
Figure 33. China Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Sevoflurane Anesthesia Sales Market Share by Country (2019-2030)
Figure 44. Latin America Sevoflurane Anesthesia Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Sevoflurane Anesthesia Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Sevoflurane Anesthesia Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Sevoflurane Anesthesia Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Sevoflurane Anesthesia by Type (2019-2030)
Figure 54. Global Revenue Market Share of Sevoflurane Anesthesia by Type (2019-2030)
Figure 55. Global Sevoflurane Anesthesia Price (US$/Litre) by Type (2019-2030)
Figure 56. Global Sales Market Share of Sevoflurane Anesthesia by Application (2019-2030)
Figure 57. Global Revenue Market Share of Sevoflurane Anesthesia by Application (2019-2030)
Figure 58. Global Sevoflurane Anesthesia Price (US$/Litre) by Application (2019-2030)
Figure 59. Sevoflurane Anesthesia Value Chain
Figure 60. Sevoflurane Anesthesia Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
